## Abstract It has been previously shown that lymphocytes from cancer patients can kill cultivated neoplastic cells of the type carried by the lymphocyte donors and that sera from patients with growing tumors of the respective types can specifically block the tumor‐cell destruction. The present stu
Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system
✍ Scribed by S. Kumar; G. Taylor; J. K. Steward; M. A. Waghe; P. Morris-Jones
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- French
- Weight
- 893 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Lymphocytotoxicity studies were carried out in both the autochthonous and allogeneic situations in nine astrocytomas, seven medulloblastomas and two ependy‐momas. Tumour type‐specific lymphocytotoxicity was demonstrated. The degree of lymphocyte‐mediated tumour‐cell killing did not decrease with the duration of apparent clinical cure. Higher degrees of tumour‐cell killing were found in the autochthonous as compared with the allogeneic combinations. Blocking factor was demonstrated in only three patients.
📜 SIMILAR VOLUMES
## Abstract ## Background Primary germ cell tumours (GCT) of the central nervous system (CNS) are rare tumours of children and adults. As few prospective, randomised trials have been published, management decisions are often based on retrospective and historical studies, histology, age, performanc
Adrenoleukodystrophy is a disorder of long-chain fatty acid metabolism associated with adrenal cortical insufficiency and central nervous system demyelination. The central nervous system disease is unusual in that it is abrupt in onset and accompanied by a considerable infiltration of mononuclear in
## Abstract A patient with melanoma was found to have lymphocytes highly cytotoxic for autogenous tumor cells but not for fibroblasts. Autogenous serum did not block the cytotoxicity. He then received an injection of BCG into a small tumor nodule. Three weeks later, in association with accelerated
One hundred eleven patients with small cell carcinoma of the lung (SCLC) were histologically subtyped according to the recent consensus report by the Pathology Committee of the International Association for the Study of Lung Cancer. Using pretreatment material the authors examined retrospectively th